Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$165.79 - $198.03 $316,493 - $378,039
1,909 New
1,909 $378,000
Q3 2023

Nov 14, 2023

BUY
$136.29 - $225.35 $297,793 - $492,389
2,185 Added 58.96%
5,891 $871,000
Q2 2023

Aug 14, 2023

BUY
$209.98 - $240.96 $478,124 - $548,665
2,277 Added 159.34%
3,706 $809,000
Q1 2023

May 15, 2023

BUY
$205.07 - $236.53 $293,045 - $338,001
1,429 New
1,429 $312,000
Q4 2019

Feb 14, 2020

SELL
$126.52 - $156.7 $7.26 Million - $8.99 Million
-57,354 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$123.37 - $140.33 $7.08 Million - $8.05 Million
57,354 New
57,354 $7.75 Million
Q4 2018

Feb 14, 2019

SELL
$98.06 - $115.33 $3.74 Million - $4.4 Million
-38,120 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$103.52 - $115.55 $1.11 Million - $1.24 Million
-10,690 Reduced 21.9%
38,120 $4.4 Million
Q2 2018

Aug 14, 2018

BUY
$93.62 - $107.93 $4.57 Million - $5.27 Million
48,810 New
48,810 $5.06 Million

Others Institutions Holding RMD

About RESMED INC


  • Ticker RMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 146,459,008
  • Market Cap $34.9B
More about RMD
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.